Squarepoint Ops »

Aligos Therapeutics shares owned by Squarepoint Ops

Quarter-by-quarter ownership of Aligos Therapeutics (ALGS) shares owned by Squarepoint Ops from 13F filings

Historical chart of Squarepoint Ops investment in Aligos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aligos Therapeutics held by Squarepoint Ops consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aligos Therapeutics by Squarepoint Ops

Quarter filed Position value Share count Share price at filing
2025-09-30 $299k 31k 9.80
2025-06-30 $134k 19k 7.21

More positions owned by Squarepoint Ops

Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Apple (AAPL)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Ishares Tr Msci Emg Mkt Etf (EEM)
Advanced Micro Devices (AMD)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Palantir Technologies Cl A (PLTR)
Netflix (NFLX)

View all positions for Squarepoint Ops

Top funds holding Aligos Therapeutics

Woodline Partners
Deep Track Capital
Alyeska Investment Group
Sio Capital Management
Readystate Asset Management
Vanguard Group
Adage Capital Partners GP
Baker Bros. Advisors
Hillhouse Capital Advisors
LPL Financial
Renaissance Technologies
Geode Capital Management
Two Sigma Investments
Squarepoint Ops
UBS Group

View all funds holding Aligos Therapeutics